Söndag 27 April | 06:10:44 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-02-12 08:30 Bokslutskommuniké 2025
2025-10-23 08:30 Kvartalsrapport 2025-Q3
2025-08-21 08:30 Kvartalsrapport 2025-Q2
2025-05-16 N/A X-dag ordinarie utdelning NANECH 0.00 SEK
2025-05-15 N/A Årsstämma
2025-04-30 08:30 Kvartalsrapport 2025-Q1
2025-02-13 - Bokslutskommuniké 2024
2024-10-24 - Kvartalsrapport 2024-Q3
2024-08-22 - Kvartalsrapport 2024-Q2
2024-04-30 - Kvartalsrapport 2024-Q1

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
NanoEcho är verksamt inom sjukvården, med huvudsaklig fokus inom rektalcancerdiagnostik. Bolaget är verksamt i kliniskt skede, där man utvecklar en ny diagnostisk metod för att fastställa om tidig rektalcancer har spridit sig till närliggande lymfkörtlar. Metoden ämnar ge en korrekt diagnos och individanpassad behandling. NanoEcho grundades år 2013 och har sitt huvudkontor i Lund.
2023-10-27 09:00:00

NanoEcho has participated in a meeting with international researchers in magnetomotive ultrasound as well as leading colorectal cancer physicians. At the meeting, NanoEcho's imaging system was presented and discussed and its potential to improve health care for rectal cancer patients.

This week, NanoEcho participated in a meeting in Glasgow together with internationally prominent researchers in magnetomotive ultrasound and leading physicians in colorectal cancer from Strathclyde University, Glasgow University, Edinburgh University and Lund University.

The discussions focused on trends and challenges in rectal cancer diagnostics. It was confirmed that the challenges identified by NanoEcho, related to the lack of reliable diagnostics for the spread of rectal cancer, are shared by the international medical profession. During the meeting, NanoEcho had the opportunity to present and demonstrate the NanoEcho imaging system.

Linda Persson, CEO of NanoEcho, held a seminar entitled "High-resolution Images for Improved Rectal Cancer Diagnosis” which generated many interesting discussions about what it takes to bring innovation to the market.

"It was very rewarding and inspiring to present our system and receive such positive feedback from international participants. This strengthens our international network, which is important before our upcoming clinical registration study", says Linda Persson, CEO of NanoEcho.